W. Lloyd Clark

3.6k total citations · 1 hit paper
30 papers, 2.1k citations indexed

About

W. Lloyd Clark is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Neurology. According to data from OpenAlex, W. Lloyd Clark has authored 30 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Ophthalmology, 17 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Neurology. Recurrent topics in W. Lloyd Clark's work include Retinal Diseases and Treatments (23 papers), Retinal and Optic Conditions (22 papers) and Retinal Imaging and Analysis (12 papers). W. Lloyd Clark is often cited by papers focused on Retinal Diseases and Treatments (23 papers), Retinal and Optic Conditions (22 papers) and Retinal Imaging and Analysis (12 papers). W. Lloyd Clark collaborates with scholars based in United States, Germany and Japan. W. Lloyd Clark's co-authors include David M. Brown, David S. Boyer, Robert Vitti, Alyson J. Berliner, Jeffrey S. Heier, Julia A. Haller, Oliver Zeitz, Rupert Sandbrink, Charles C. Wykoff and Husain Kazmi and has published in prestigious journals such as Ophthalmology, American Journal of Ophthalmology and Investigative Ophthalmology & Visual Science.

In The Last Decade

W. Lloyd Clark

30 papers receiving 2.0k citations

Hit Papers

Intravitreal Aflibercept for Macular Edema Following Bran... 2014 2026 2018 2022 2014 100 200 300

Peers

W. Lloyd Clark
W. Lloyd Clark
Citations per year, relative to W. Lloyd Clark W. Lloyd Clark (= 1×) peers Ioannis Vergados

Countries citing papers authored by W. Lloyd Clark

Since Specialization
Citations

This map shows the geographic impact of W. Lloyd Clark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Lloyd Clark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Lloyd Clark more than expected).

Fields of papers citing papers by W. Lloyd Clark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Lloyd Clark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Lloyd Clark. The network helps show where W. Lloyd Clark may publish in the future.

Co-authorship network of co-authors of W. Lloyd Clark

This figure shows the co-authorship network connecting the top 25 collaborators of W. Lloyd Clark. A scholar is included among the top collaborators of W. Lloyd Clark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Lloyd Clark. W. Lloyd Clark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Campochiaro, Peter A., David Eichenbaum, Margaret Chang, et al.. (2024). Interim Results of the Phase III Portal Extension Trial of the Port Delivery System with Ranibizumab in Neovascular Age-Related Macular Degeneration. Ophthalmology Retina. 9(2). 144–155. 2 indexed citations
2.
Wykoff, Charles C., V. Diana, W. Lloyd Clark, et al.. (2024). Longitudinal Changes in Diabetic Retinopathy Severity: Learnings from PANORAMA. Ophthalmology Retina. 9(1). 91–94. 1 indexed citations
3.
Wykoff, Charles C., V. Diana, Roger A. Goldberg, et al.. (2023). Ocular and Systemic Risk Factors for Disease Worsening Among Patients with NPDR. Ophthalmology Retina. 8(4). 399–408. 3 indexed citations
4.
Merrill, Pauline T., W. Lloyd Clark, Alay Banker, et al.. (2020). Efficacy and Safety of Intravitreal Sirolimus for Noninfectious Uveitis of the Posterior Segment. Ophthalmology. 127(10). 1405–1415. 26 indexed citations
5.
Payne, John F., Charles C. Wykoff, W. Lloyd Clark, et al.. (2020). Long-term outcomes of treat-and-extend ranibizumab with and without navigated laser for diabetic macular oedema: TREX-DME 3-year results. British Journal of Ophthalmology. 105(2). 253–257. 16 indexed citations
6.
Clark, W. Lloyd, et al.. (2019). Baseline characteristics associated with early visual acuity gains after ranibizumab treatment for retinal vein occlusion. BMC Ophthalmology. 19(1). 11–11. 10 indexed citations
7.
Nguyen, Quan Dong, Pauline T. Merrill, & W. Lloyd Clark. (2017). Efficacy and Safety Results From the SAKURA Program: Two Phase III Studies of Intravitreal Sirolimus Every Other Month for Non-infectious Uveitis of the Posterior Segment. Investigative Ophthalmology & Visual Science. 58(8). 517–517. 2 indexed citations
8.
Wykoff, Charles C., William C. Ou, Daniel E. Croft, et al.. (2017). Neovascular age-related macular degeneration management in the third year: final results from the TREX-AMD randomised trial. British Journal of Ophthalmology. 102(4). 460–464. 33 indexed citations
9.
Wykoff, Charles C., William C. Ou, Rahul N. Khurana, et al.. (2017). Long-term outcomes with as-needed aflibercept in diabetic macular oedema: 2-year outcomes of the ENDURANCE extension study. British Journal of Ophthalmology. 102(5). 631–636. 29 indexed citations
10.
Wykoff, Charles C., William C. Ou, David M. Brown, et al.. (2017). Randomized Trial of Treat-and-Extend versus Monthly Dosing for Neovascular Age-Related Macular Degeneration. Ophthalmology Retina. 1(4). 314–321. 93 indexed citations
11.
Pielen, Amelie, W. Lloyd Clark, David S. Boyer, et al.. (2017). Integrated results from the COPERNICUS and GALILEO studies. Clinical ophthalmology. Volume 11. 1533–1540. 29 indexed citations
12.
Nguyen, Quan Dong, Pauline T. Merrill, W. Lloyd Clark, et al.. (2016). Intravitreal Sirolimus for Noninfectious Uveitis: A Phase III Sirolimus Study Assessing Double-masKed Uveitis TReAtment (SAKURA). Ophthalmology. 123(11). 2413–2423. 58 indexed citations
13.
Payne, John F., Charles C. Wykoff, W. Lloyd Clark, et al.. (2016). Randomized Trial of Treat and Extend Ranibizumab with and without Navigated Laser for Diabetic Macular Edema. Ophthalmology. 124(1). 74–81. 73 indexed citations
14.
Patterson, Michael, Chris Bergstrom, W. Lloyd Clark, Hans E. Grossniklaus, & John F. Payne. (2015). SEVERE PANUVEITIS, RETINAL VASCULITIS, AND OPTIC DISK GRANULOMA SECONDARY TO SARCOIDOSIS. Retinal Cases & Brief Reports. 10(4). 341–344. 1 indexed citations
15.
Campochiaro, Peter A., W. Lloyd Clark, David S. Boyer, et al.. (2014). Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion. Ophthalmology. 122(3). 538–544. 310 indexed citations breakdown →
16.
Clark, W. Lloyd, et al.. (2013). Two-Year Results of the COPERNICUS Study Evaluating Intravitreal Aflibercept Injection (IAI) for Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO). Investigative Ophthalmology & Visual Science. 54(15). 4515–4515. 2 indexed citations
17.
Boyer, David S., Jeffrey S. Heier, David M. Brown, et al.. (2012). Vascular Endothelial Growth Factor Trap-Eye for Macular Edema Secondary to Central Retinal Vein Occlusion. Ophthalmology. 119(5). 1024–1032. 199 indexed citations
18.
Michels, Mark, et al.. (2004). METASTATIC BREAST CARCINOMA TO THE VITREOUS. Retina. 24(2). 226–230. 3 indexed citations
19.
Clark, W. Lloyd. (1998). Primary Intraocular Posttransplantation Lymphoproliferative Disorder. Archives of Ophthalmology. 116(12). 1667–1667. 18 indexed citations
20.
Robinson, Timothy P., et al.. (1961). Experimental preservation of fresh beef with antibiotics and radiation.. Food technology. 15. 13–15. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026